Apria, Inc.

We are a leading provider of integrated home healthcare equipment and related services in the United States. We offer a comprehensive range of products and services for in-home care and delivery across three core service lines: (1) home respiratory therapy (including home oxygen and non-invasive ventilation (“NIV”) services); (2) obstructive sleep apnea (“OSA”) treatment (including continuous positive airway pressure (“CPAP”) and bi-level positive […]

February 3, 2021 Read More

Music Acquisition Corp.

We intend to concentrate our efforts on identifying businesses that are either directly or indirectly connected with the music sector, with particular emphasis on businesses where our significant strategic and operational expertise and long-standing position within the music industry will be a value-additive proposition to potential target businesses. The rapid growth in the music sector driven by […]

February 2, 2021 Read More

Kernel Group Holdings, Inc.

We intend to capitalize on the ability of our management team and Advisory Board to identify, acquire and manage a business in the Commerce Enablement, Supply Chain, Logistics and related Technology Infrastructure sectors. The ideal target is a business that can benefit from our accomplished track record of founding, operating, investing, acquiring and transforming businesses […]

Read More

G Squared Ascend I Inc.

We intend to focus our search within the technology sector, and specifically within six core verticals or megatrends described as: Software-as-a-Service (SaaS); Online Marketplaces; Mobility 2.0/Logistics; FinTech/InsurTech; New Age Media and Sustainability.  Our sponsor is an affiliate of G Squared Equity Management LP (“G Squared”), a registered investment adviser and a venture capital fund manager […]

Read More

Ares Acquisition Corporation

While we may pursue an initial business combination target in any industry or sector, geography, or stage of its corporate evolution, we do not currently contemplate targeting a company in the fossil fuel energy industry, including the upstream, midstream and energy services sub-sectors, and we intend to focus our search in North America, Europe or […]

February 1, 2021 Read More

Thimble Point Acquisition Corp.

 We currently intend to focus on high-growth software and technology-enabled companies that are disrupting large and established industries and markets.  The members of our management team are associated with the Pritzker Vlock Family Office, a multi-billion-dollar family office that invests in companies and their management teams with industry changing ideas, as well as LaunchCapital, a […]

Read More

Angion Biomedica

We are a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Our goal is to transform the treatment paradigm for patients suffering from these potentially life-threatening conditions for which there are no approved medicines or where existing approved medicines have […]

Read More

Lucira Health, Inc.

We are a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. We developed a testing platform that produces centralized-laboratory-accurate molecular testing in a single-use and consumer-friendly test kit that is powered by two AA batteries and fits in the palm of a hand.  We believe the novel coronavirus, or COVID-19, pandemic has […]

Read More

Viant Technology Inc.

We are an advertising software company. Our software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. Programmatic advertising is rapidly taking market share from traditional ad sales channels, which require more staffing, offer less transparency and involve higher costs to buyers. Our demand side platform (“DSP”), Adelphic, is […]

Read More

Terns Pharmaceuticals, Inc.

We are a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. NASH is a severe form of non-alcoholic fatty liver disease, or NAFLD, that affects up to 15 million people in the United States, and up to 6% of the global population, for […]

Read More
Page 217 of 303« First...102030...215216217218219...230240250...Last »